Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-11

Clinical Trial Update: Different Oral Colonization of Gram-negative Bacteria in ICU Patients When Using Chlorhexidine at 0.12% Versus Chlorhexidine at 2.0% [Phase 3]

View source ↗

Summary

Phase 3 trial investigating how different chlorhexidine concentrations (0.12% vs 2.0%) affect oral colonization by Gram-negative bacteria in ICU patients, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine (2.0%) (chlorhexidine)
  • Chlorhexidine 0.12% (Chlorhexidine digluconate)

Snippet

Sponsor: Universidad de Guanajuato | Conditions: Chlorhexidine, Ventilator Associated Pneumonia | Phase 3 | Status: UNKNOWN